Federal Bill C-368 aims to repeal sections of the Budget Implementation Act which redefined Natural Health Products (NHPs) and subjected the NHP industry to heightened regulation and excessive fines without appropriate consultation, debate, or deference to previous recommendations made by the Standing Committee on Health in their 1998 report, Natural Health Products: A New Vision.
In May 2024, CARB-TCMPA issued a letter in support of Bill C-368 as it reaffirms the appropriate differentiation between pharmaceutical drugs and NHPs. Bill C-368 is essential to ensure that the regulation of NHPs remains in alignment with the unique needs and composition of the industry and that changes to the regulatory framework do not negatively impact product affordability and patient access to care.
CARB-TCMPA has now issued a letter to the House of Commons Standing Committee on Health, which is reviewing proposed amendments that would undermine the purpose of Bill C-368. We are urging the committee to reject these amendments and support the original intent of Bill C-368 to protect patients and healthcare practitioners who depend on NHPs for effective care.
Read CARB-TCMPA’s letter to the House of Commons Standing Committee on Health.